Through molecular typing technology that detects multiple variants across multiple genes, it identifies the treatment products that patients are most likely to benefit from, potential severe side effects caused by treatment, and monitor therapeutic responses. Companion diagnosis is a process conducted alongside treatment, whose role is to guide medication use. In summary, it shifts the cancer treatment concept from traditional morphological typing (by tumor location) to molecular typing (by pathogenesis).
Platform Advantages
SE75 sequencing takes only 4.5 h, the competitive sequencing speed will keep your project running more smoothly.
Sequencers, flow cells and reagents are self-developed and produced in-house, ensuring reliable delivery.
Building on the company’s years of expertise in microbiology, this platform includes a database of over 20,000 microbial species.
Compatible with mainstream libraries on the market, eliminating debugging costs.
Sikun Integrated NGS Solution
Integrates Extraction, Library Construction, and Quality Control in One System.

Eliminates Tedious Operational Procedures, Ultra-Simple Operation.

Reduces analysis time to accelerate
critical clinical and research decisions.
